Viewing Study NCT03720457


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2025-12-30 @ 7:12 AM
Study NCT ID: NCT03720457
Status: UNKNOWN
Last Update Posted: 2021-08-31
First Post: 2018-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.
Sponsor: Hrain Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module